Position in BCYC
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$149,217
-$32,568 QoQ
Shares Held
32,159
+25.2% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in BCYC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,296,725,913 across 562 Biotechnology names. BCYC ranks #342 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in BCYC
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $149,217 | 32,159 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $181,785 | 25,676 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $88,026 | 11,373 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $231,955 | 33,375 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $617,239 | 72,702 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,853,054 | 132,361 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $273,053 | 12,066 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $322,523 | 15,935 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $248,551 | 9,982 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $201,591 | 11,150 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $227,117 | 11,305 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $321,858 | 12,612 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $295,482 | 13,892 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $383,082 | 12,942 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $662,327 | 28,475 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $217,569 | 12,966 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $389,829 | 8,884 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $54,296 | 892 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $35,185 | 846 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $52,067 | 1,715 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $10,514 | 352 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $4,200 | 234 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $9,429 | 495 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $35,965 | 2,285 | Shares | Sole | 2020-07-31 | |
| No filing history on record for this holder in this stock. | ||||||